Tag: AI Drug Discovery
Raygun AI resizes natural proteins without losing their function
Duke University's Raygun AI can shrink or enlarge natural proteins without breaking their shape, opening new options for biologic drug…
Schrodinger launches Bunsen AI co-scientist for physics-powered drug discovery
Schrodinger launched Bunsen, an agentic AI co-scientist combining physics-based simulation with LLMs for drug discovery.
AI shrinks drug discovery timelines with data-driven biologics design
MIT Technology Review explores how AstraZeneca and others use AI to compress drug discovery and target previously untreatable diseases.
Bristol Myers Squibb partners with Nvidia on AI factory for drug discovery
BMS is building dedicated AI compute infrastructure with Nvidia to accelerate molecular modeling and drug discovery.
Belgian techbio startup Sightera raises $3.2M for AI-designed molecular glues
Belgian AI drug discovery startup Sightera Biosciences raises $3.2M to advance molecular glue therapies for hard-to-treat cancers and fibrosis.
Boehringer Ingelheim taps Immunai AI platform in $15 million deal
Boehringer Ingelheim pays $15M for Immunai's AI platform to find shared T-cell targets across cancer and autoimmune disease.
Mount Sinai AI model maps how genes function together in cells
Scientists at Mount Sinai developed a gene set foundation model that learns how genes behave across thousands of biological contexts,…
Over 173 AI-designed drugs now in trials as FDA decision nears
More than 173 AI-originated drug programs are in clinical development as of early 2026, with the first potential FDA approval…